Biography
Dr Abhi Pal is a Staff Specialist Medical Oncologist at Liverpool Hospital and Bankstown Hospital. He has a clinical focus on early phase cancer clinical trials and thoracic malignancies. His research focus is on improving diversity in cancer clinical trials, and equity in cancer care, with a particular focus on multicultural communities and populations with a non English language preference.
My Qualifications
BSc (Hons)...view more
Dr Abhi Pal is a Staff Specialist Medical Oncologist at Liverpool Hospital and Bankstown Hospital. He has a clinical focus on early phase cancer clinical trials and thoracic malignancies. His research focus is on improving diversity in cancer clinical trials, and equity in cancer care, with a particular focus on multicultural communities and populations with a non English language preference.
My Qualifications
BSc (Hons) MBBS FRACP PhD
My Research Activities
Vinod S, Khoo A, Berry M, Bell K, Ahmed E, Campisi J, Gollon C, Pal A, Seto SK, Tcharkhedian E, Tran T, Bray V. Implementation and evaluation of a geriatric-oncology model of care for older adults with lung cancer. J Geriatr Oncol. 2023 Jul 6:101578. doi: 10.1016/j.jgo.2023.101578. Epub ahead of print. PMID: 37422350. Nindra Letter
Nindra, U., Pal, A. and Lee, C.S. (2023), Precision medicine in Australia: now is the time to get it right. Med J Aust, 218: 330-330. https://doi.org/10.5694/mja2.51887
Nindra U, Shahnam A, Stevens S, Pal A, Nagrial A, Lee J, Yip PY, Adam T, Boyer M, Kao S, Bray V. Influence of EGFR mutation status and PD-L1 expression in stage III unresectable non-small cell lung cancer treated with chemoradiation and consolidation durvalumab. Asia Pac J Clin Oncol. 2023 Feb 28. doi: 10.1111/ajco.13940. Epub ahead of print. PMID: 36855021.
Nindra U, Shahnam A, Stevens S, Pal A, Nagrial A, Lee J, Yip PY, Adam T, Boyer M, Kao S, Bray V. Elevated neutrophil-to-lymphocyte ratio (NLR) is associated with poorer progression-free survival in unresectable stage III NSCLC treated with consolidation durvalumab. Thorac Cancer. 2022 Nov;13(21):3058-3062. doi: 10.1111/1759-7714.14646. Epub 2022 Sep 16. PMID: 36111516; PMCID: PMC9626316.
Nindra, Udit, Jun Hee Hong, Bavanthi Balakrishnar, Abhijit Pal, and Wei Chua. "Review of Toxicities of Parp Inhibitors in Metastatic Castrate Resistant Prostate Cancer." Clinical Genitourinary Cancer (2022).
Papadatos-Pastos, Dionysis, Wei Yuan, Abhijit Pal, Mateus Crespo, Ana Ferreira, Bora Gurel, Toby Prout, et al. "Phase 1, Dose-Escalation Study of Guadecitabine (Sgi-110) in Combination with Pembrolizumab in Patients with Solid Tumors." Journal for ImmunoTherapy of Cancer 10, no. 6 (2022): e004495.
Stapleton, Sarah E., Anne‐Sophie Darlington, Anna Minchom, Abhijit Pal, Florence Raynaud, and Theresa Wiseman. "Assessing Cognitive Toxicity in Early Phase Trials‐What Are We Missing?". Psycho‐Oncology 31, no. 3 (2022): 405-15.
Tiu, Crescens, Rajiv Shinde, Abhijit Pal, Andrea Biondo, Alex Lee, Nina Tunariu, Shaman Jhanji, et al. "A Wolf in Sheep's Clothing: Systemic Immune Activation Post Immunotherapy." Journal of Immunotherapy and Precision Oncology 4, no. 4 (2021): 189-95.
Welti, Jonathan, Adam Sharp, Nigel Brooks, Wei Yuan, Christopher McNair, Saswati N. Chand, Abhijit Pal, et al. "Targeting P300/Cbp Axis in Lethal Prostate Cancer." Cancer Discovery (2021).
Pal, Abhijit, Sarah Stapleton, Christina Yap, Julia Lai-Kwon, Robert Daly, Dimitrios Magkos, Bindumalini Rao Baikady, et al. "Study Protocol for a Randomised Controlled Trial of Enhanced Informed Consent Compared to Standard Informed Consent to Improve Patient Understanding of Early Phase Oncology Clinical Trials (Consent)." British Medical Journal Open 11, no. 9 (2021): e049217.
Pal, Abhijit*, Rajiv Shinde*, Manuel Selvi Miralles, Paul Workman, and Johann de Bono. "Applications of Liquid Biopsy in the Pharmacological Audit Trail for Anticancer Drug Development." Nature Reviews Clinical Oncology 18, no. 7 (2021): 454-67. (* - co first author)
Biondo, Andrea*, Abhijit Pal*, Ruth Riisnaes, Rajiv Shinde, Crescens Tiu, Fran Lockie, Chloe Baker, et al. "Research Related Tumour Biopsies in Early-Phase Trials with Simultaneous Molecular Characterisation–a Single Unit Experience." Cancer Treatment and Research Communications 27 (2021): 100309. (* - co first author)
Lai-Kwon, Julia, Crescens Tiu, Abhijit Pal, Sachin Khurana, and Anna Minchom. "Moving Beyond Epidermal Growth Factor Receptor Resistance in Metastatic Non-Small Cell Lung Cancer-a Drug Development Perspective." Critical Reviews in Oncology/Hematology 159 (2021): 103225.
Ahmadzada, Tamkin, Wendy A. Cooper, Mikaela Holmes, Annabelle Mahar, Helen Westman, Anthony J. Gill, Ina Nordman, Po Yee Yip, Abhijit Pal, Rob Zielinski, Nick Pavlakis, Adnan Nagrial, Dariush Daneshvar, Daniel Brungs, Deme Karikios, Vesna Aleksova, Juliet Burn, Rebecca Asher, Georges E. Grau, Elham Hosseini-Beheshti, Glen Reid, Stephen Clarke, and Steven Kao. "Retrospective Evaluation of the Use of Pembrolizumab in Malignant Mesothelioma in a Real-World Australian Population." JTO Clinical and Research Reports 1, no. 4 (2020): 100075.
Pal, Abhijit, Eugene Moylan, and Wei Chua. "Is It Time to Reconsider ‘Routine’ blood Tests in the Hospital Inpatient Setting?". Internal Medicine Journal 49, no. 12 (2019): 1554-55.
Sheikh, Mohamud, Shu Wang, Abhijit Pal, C. Raina MacIntyre, Nicholas Wood, and Hasantha Gunesekera. "Vitamin D Deficiency in Refugee Children from Conflict Zones." Journal of Immigrant and Minority Health 13, no. 1 (2011): 87-93.
Sheikh, Mohamud, Abhijit Pal, Shu Wang, C. Raina MacIntyre, Nicholas J. Wood, David Isaacs, Hasantha Gunasekera, et al. "The Epidemiology of Health Conditions of Newly Arrived Refugee Children: A Review of Patients Attending a Specialist Health Clinic in Sydney." Journal of Paediatrics and Child Health 45, no. 9 (2009): 509-13.